Helius Medical Technologies to Present at the Virtual Summer Summit on June 9th
June 05 2020 - 7:05AM
Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius”
or the “Company”), a neurotech company focused on neurological
wellness, today announced that management will participate in the
Virtual Summer Summit, which is being held from June 9th-12th.
Management will present on Tuesday, June 9th at 4:30 p.m. Eastern
Time.
A live audio webcast of the presentation will be
provided under the ‘Events’ section of the Helius Medical
Technologies investor relations website at
https://heliusmedical.com/index.php/investor-relations/events/upcoming-events.
An archive of the webcast will be available for replay following
the conference.
About Helius Medical Technologies, Inc.
Helius Medical Technologies is a neurotech company focused on
neurological wellness. The Company’s purpose is to develop, license
and acquire unique and non-invasive platform technologies that
amplify the brain’s ability to heal itself. The Company’s first
commercial product is the Portable Neuromodulation Stimulator
(PoNS™). For more information, visit www.heliusmedical.com.
About the PoNS™ Device and PoNS Treatment™
The Portable Neuromodulation Stimulator (PoNS) is an authorized
class II, non-implantable medical device authorized for sale in
Canada. PoNS is intended as a short term treatment (14 weeks) of
gait deficit due to mild and moderate symptoms from MS and is to be
used in conjunction with physical therapy and indicated as a short
term treatment (14 weeks) chronic balance deficit due to
mild-to-moderate traumatic brain injury and is to be used in
conjunction with physical therapy. The PoNS is an investigational
medical device in the United States, the European Union, and
Australia, and is currently under review for clearance by the AUS
Therapeutic Goods Administration. PoNS Treatment is currently not
commercially available in the United States, the European Union or
Australia.
Investor Relations Contact:
Westwicke Partners on behalf of Helius Medical Technologies,
Inc.
Mike Piccinino, CFA
investorrelations@heliusmedical.com
Helius Medical Technolog... (NASDAQ:HSDT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Helius Medical Technolog... (NASDAQ:HSDT)
Historical Stock Chart
From Sep 2023 to Sep 2024